Metronom

Skip To Content

13th International Conference on Advanced Technologies and Treatments for Diabetes

The innovative 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020) gathered over 3,800 participants from more than 80 different countries. A scientific program was delivered by renowned international experts and the latest developments in new insulin analogues and delivery systems, insulin pumps, glucose sensors, closed-loop systems, devices for diabetic prevention, artificial pancreas, new technologies for treating obesity and many more were showcased.

This is the context in which Metronom Health shared its CGM program, showcasing the company's unique, revolutionary and proprietary opto-enzymatic glucose sensing technology, as well as its Target Product Profile, user-centric application, and overall vision.

The event was also a great opportunity for Metronom’s team members to network with health care professionals and other experts in the field of diabetes, gathering interesting feedback on its project, aiming at constantly evolve Metronom’s solution development in line with the needs of the various stake holders, starting with the end users. 

Alert

You are now leaving the website of Metronom Health, Inc. and entering a third-party website over which Metronom Health, Inc. has no control. Neither Metronom Health, Inc. nor its subsidiaries or affiliates, are responsible for the content of third-party websites hyperlinked from this page or any hyperlink contained in a hyperlinked website, nor do they guarantee or endorse the information, recommendations, products or services offered on third-party websites.

Continue Cancel